Abstract:
Disclosed herein are compositions and methods for treating, ameliorating or preventing a retinal disease or condition; improving a photopic (day light) vision; for improving correcting visual acuity, improving macular function, improving a visual field, or improving scotopic (night) vision by administration of retinal progenitor cells. The subject matter described herein also provides cell populations comprising retinal progenitor cells and methods of isolation thereof.
Abstract:
Disclosed herein are compositions and methods for treating, ameliorating or preventing a retinal disease or condition; improving a photopic (day light) vision; for improving correcting visual acuity, improving macular function, improving a visual field, or improving scotopic (night) vision by administration of retinal progenitor cells. The subject matter described herein also provides cell populations comprising retinal progenitor cells and methods of isolation thereof.
Abstract:
An array substrate and a method for fabricating the same are disclosed. The method for fabricating the array substrate comprises: forming a pattern of a gate electrode (2) and a common electrode (3) on a substrate (1); forming a pattern of a gate insulating layer (4), an active layer (5), a source/drain electrode layer (6) and a first passivation layer (7), wherein the first passivation layer (7) has a via hole and a thin film transistor (TFT) channel window, and the TFT channel window is located above the gate electrode (2); forming a TFT channel and a pixel electrode (9) with slits, wherein the pixel electrode (9) is connected to one of the source/drain electrode (6) through the via hole. The method is not only simple and stable but also improves the TFT quality.
Abstract:
In the field of communications technologies, a down sampling method and a down sampling device are provided, to enable the energy of a down sampling point obtained in down sampling to be as large as possible. The down sampling method includes: extracting energy statistical values of sampling point sets in a current period; selecting a sampling position corresponding to a sampling point set with the largest energy statistical value as a down sampling position; and performing down sampling according to the down sampling position.
Abstract:
The present invention discloses a method for receiving and processing data. The method includes: convoluting a channel estimate value of a receive end with an SCH signal transmitted by a transmit end on an SCH and obtaining an SCH signal in a receive signal of the receive end; evaluating a difference between the receive signal and the SCH signal in the receive signal. An apparatus, and a user terminal are also disclosed in the present invention. By using the method and apparatus of the present invention, the SCH signal in a receiver may be restored and removed from the receive signal, and interference of the SCH on other channels may be eliminated, thereby improving performance of the receiver.
Abstract:
Embodiments of the present invention provide a method and a system for removing a Radio Frequency (RF) Direct Current (DC) offset in a signal. The method includes: subtracting a canceling DC from a signal carrying an RF DC offset and generating an RF DC offset residual; outputting the signal when the RF DC offset residual in the signal is zero; adjusting the canceling DC according to the RF DC offset residual in the signal if the RF DC offset residual is not zero. The system includes a receiver, an RF DC offset canceling unit, a determining unit, a canceling DC adjusting unit, and an output unit. With embodiments of the present invention, the RF DC offset in the signal may be effectively removed.
Abstract:
The invention relates to methods and compositions for inhibiting metastasis, such as by inhibiting FOXC2 expression or activity. The invention further relates to methods of prognosticating, diagnosing, and assisting in the diagnosis of metastasis in an individual, or of determining the metastatic potential of a tumor. The invention further relates to methods of identifying agents which inhibit metastasis.
Abstract:
Ghrelin O-acyltransferase (GOAT) is inhibited with designed small molecules. Methods comprise contacting the GOAT with an inhibitor and detecting a resultant inhibition.
Abstract:
Ghrelin is acylated ghrelin O-acyltransferase. Ghrelin O-acyltransferase assays comprise contacting a mixture of ghrelin and recombinant ghrelin O-acyltransferase with an agent; and detecting a resultant decrease in acylation of the ghrelin by the acyltransferase.
Abstract:
Transgenic mice expressing human tissue factor which are useful for evaluating pharmacologic agents which interact with human tissue factor and for investigating diseases associated with human tissue factor.